Umbilical Cord Blood as a Source of Novel Reagents and Therapeutics
Authors:
- 7 March 2019
- book chapter
- Published by Springer Nature
- p. 75-82
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Alternative donors for allogeneic hematopoietic stem cell transplantation in poor-risk AML in CR1Blood Advances, 2017
- Related haploidentical donors are a better choice than matched unrelated donors: CounterpointBlood Advances, 2017
- Related haploidentical donors are a better choice than matched unrelated donors: PointBlood Advances, 2017
- Erythropoietin modulation is associated with improved homing and engraftment after umbilical cord blood transplantationBlood, 2016
- Cord blood transplantation: rewind to fast forwardBone Marrow Transplantation, 2016
- Banking or Bankrupting: Strategies for Sustaining the Economic Future of Public Cord Blood BanksPLOS ONE, 2015
- Umbilical cord blood donation: public or private?Bone Marrow Transplantation, 2015
- Umbilical cord blood banking: from personal donation to international public registries to global bioeconomyJournal of Blood Medicine, 2014
- Umbilical cord blood transplantation: the first 25 years and beyondBlood, 2013
- New Approaches for Improving Engraftment after Cord Blood TransplantationTransplantation and Cellular Therapy, 2010